machineMD has been granted an InnoCheque funding by Innosuisse for its collaboration with the FHNW University of Applied Sciences and Arts Northwestern Switzerland. The objective is to demonstrate in...

Bern, Switzerland & San Diego, USA  – machineMD, an award-winning medical device company at the forefront of neurodiagnostic innovation, today announced a strategic investment from Topcon Healthcare,

MATTER, the premier healthcare incubator and innovation hub, with support from theLundbeck US Charitable Fund, a corporate foundation dedicated to responsibly giving back to the community, has...

A recent study by Ana Coito PhD, Avantika Naidu PhD, Julian Lehmann MS, Bruno Hauser MS, Dominik Brügger PhD, and Mathias Abegg MD PhD evaluated the test-retest reliability of gaze precision of neos®...

Automated Measurement of Strabismus Angle Using a Commercial Virtual Reality Headset

Current clinical measurements of strabismus angles (SAs) are manual and require a skilled examiner and active...

Use of a Novel Virtual Reality-Based Pupillography Device for Glaucoma Management: Cross-Sectional Cohort Pilot Study

Background: Current standard methods in monitoring glaucoma progression, like...

Zurich is home to ebovis, the world's first ophthalmology practice to offer a standardized, complete, apparative eye examination. The neos™ examination device developed by machineMD, the world's...

machineMD was awarded as the winner of the VIVE XR Healthcare Challenge during the opening day of MEDICA 2024.

The VIVE XR Healthcare Challenge is a special prize of the Healthcare Innovation World...

For the past year, PD Dr. Anke Salmen and her team from the Department of Neurology at St. Josef-Hospital, Bochum University Hospital have been using the innovative technology from machineMD in their...

October 14^th, 2024 – Bern, Switzerland – machineMD, a Swiss medical device company innovating at the intersection of neuroscience and ophthalmology, is proud to announce its visionary medical device,...